Carnitine Levels in Skeletal Muscle, Blood, and Urine in Patients with Primary Carnitine Deficiency During Intermission of l-Carnitine Supplementation

Background: Primary carnitine deficiency (PCD) is a disorder of fatty acid oxidation with a high prevalence in the Faroe Islands. Only patients homozygous for the c.95A>G (p.N32S) mutation have displayed severe symptoms in the Faroese patient cohort. In this study, we investigated carnitine level...

Full description

Bibliographic Details
Main Authors: Rasmussen, J., Thomsen, J. A., Olesen, J. H., Lund, T. M., Mohr, M., Clementsen, J., Nielsen, O. W., Lund, A. M.
Format: Text
Language:English
Published: Springer Berlin Heidelberg 2015
Subjects:
Article
Faroe Islands
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375125
http://www.ncbi.nlm.nih.gov/pubmed/25665836
https://doi.org/10.1007/8904_2014_398
Description
Summary:Background: Primary carnitine deficiency (PCD) is a disorder of fatty acid oxidation with a high prevalence in the Faroe Islands. Only patients homozygous for the c.95A>G (p.N32S) mutation have displayed severe symptoms in the Faroese patient cohort. In this study, we investigated carnitine levels in skeletal muscle, plasma, and urine as well as renal elimination kinetics before and after intermission with l-carnitine in patients homozygous for c.95A>G.

Similar Items